NCT04385745

Brief Summary

The study purpose is to investigate long-term biodegradation process of the polylactide-co-glycolide (PLGA) intramedullary nails, used in treating the forearm shaft fractures in children. The primary objective of the study is to determine the stage of biodegradation of the polylactide-co-glycolide intramedullary nails, compared with the time since operation. Biodegradation is to be evaluated by using Magnetic Resonance Imaging (MRI). Potential adverse events, being related to the biodegradation process of the implant, will be recognized: fluid accumulation, sinus formation, osteolysis, swelling, cyst formation and other soft-tissue reactions in the surroundings of the former fracture will be evaluated. Radiographic recovery at least 4 years after the implant operation is secondary aims of the study. Radiographic investigation (plain radiographs in lateral and anterior-posterior views) are taken to evaluate the signs of bone healing after the long-bone diaphysis fracture, including the resolution of the previous callus formation, tubularization of the long-bones around the previous fracture area and remodeling of the angular and rotational alignment. Clinical recovery in the long-term (at least 4 years) is another secondary aim of the study. Prospective observational study will be performed. The study population comprises all the cases who were participating in the previous RCT ("BIOABSORBABLE INTRAMEDULLARY NAIL FIXATION OF FOREARM FRACTURES IN CHILDREN") and were therefore treated by means of biodegradable intramedullary nailing in years 2010 to 2015 (N=16). All these patients will be invited and at least 4-year follow-up visit is performed at out-hospital clinics in the study institutions and radiographs and MRI will be taken. Flynn's criteria, MAYO elbow performance score and mini-DASH will be used. Health-related quality of life is to be analysed by using Pediatric Quality of Life Inventory (PedsQL). Visual analogue scale will be used for determining residual pain. A comprehensive analysis concerning the radiographic bone healing, according to Lane-Sandhu -scoring is determined and biodegradation of the implants, including the tricalciumphosphate tip will be evaluated by using MRI. Number of Patients: N=15 Diagnosis and Main Criteria for Inclusion and Exclusion: The study cases of the previous original research, described above, will be used to comprise the study population of the current project. The subject and/or guardian are invited to the study by a postal letter and by a call in case of no show. A signed and dated informed consent is required upon the participation. Costs: The patients are to be investigated for long-term recovery according to the normal treatment protocol and no extra costs are caused for the patients or the institutes. The reason for further long-term follow-up and further imaging at four years' mark is that the implants were still visible in the patients at their last follow-up visit in two years' mark, in the previous research that has been terminated. Safety and ethical consideration: There are no health-related issues in clinical investigation and MRI of the patients. The plain radiographs of the upper extremities predispose the participants to radiation, with equivalence to 1-2 days of background radiation (www.stuk.fi, radiation doses). However, radiographs are not taken of gravidae females. The study causes burden for the participants due to follow-up visit. In case of children and adolescents, the parents' presence is appreciated. However, long-term follow-up is justified because of the history of several injury and invasive surgical treatment performed and in order to certain the final degradation of the used implant. Statistical Methods: The radiographic and clinical findings will be reported in descriptive means. The mean, range and standard deviation (SD) will be reported for the continous variables. The issues in the short-term recovery and the potential association between the short-term findings and long-term results are analysed by using the SND test for independent variables. Further, the association of the clinical findings and subjective symptoms with the degradation stage of the implants will be investigated. Other appropriate statistical methods may also be used. All P-values are two-tailed and the level of significance is set as \<0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

3.9 years

First QC Date

May 4, 2020

Last Update Submit

June 14, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Biodegradation of the implants and remodeling. Visibility of the implant in imaging (MRI, magnetic resonance imaging)

    Implant biodegradation and the remodeling of the fractured bone are to be evaluated by using different imaging modalities to view the residual implant. The biodegradation and remodeling will be described qualitatively, by the radiologist.

    at least 4 years.

  • Biodegradation of the implants and remodeling. Visibility of the implant in imaging (radiographs)

    Implant biodegradation and the remodeling of the fractured bone are to be evaluated by using different imaging modalities to view the residual implant. The biodegradation and remodeling will be described qualitatively, by the radiologist.

    at least 4 years

Secondary Outcomes (4)

  • Clinical recovery (forearm rotation motions)

    at least 4 years postinjury

  • Clinical recovery (elbow motion)

    at least 4 years postinjury

  • Clinical recovery (carrying angle)

    at least 4 years postinjury

  • Clinical recovery (grip strength)

    at least 4 years postinjury

Study Arms (2)

Elastic Stable Intramedullary Nailing

EXPERIMENTAL

BIN (biodegradable intramedullary nailing) method will be compared with the ESIN (elastic stable intramedullary nailing)

Procedure: Biodegradable Intramedullary Nailing (BIN)

Biodegradable intramedullary nailing

EXPERIMENTAL

BIN method will be compared with the ESIN.

Procedure: Biodegradable Intramedullary Nailing (BIN)

Interventions

Unstable forearm shaft fractures are treated by the study method (BIN) or the control method (ESIN).

Also known as: Elastic Stable Intramedullary Nailing (ESIN)
Biodegradable intramedullary nailingElastic Stable Intramedullary Nailing

Eligibility Criteria

Age4 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients who have participated in the previous study, concerning the surgical treatment of forearm shaft fracture and have been treated by biodegradable intramedullary nailing (BIN), using the polylactide-co-glycolide nails (ActivaNail).

You may not qualify if:

  • The cases that have primarily been enrolled but interrupted the first study because of new fracture and been therefore surgically fixed with traditional (metallic) implants will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oulu University Hospital and University of Oulu

Oulu, 90140, Finland

Location

MeSH Terms

Conditions

Fractures, BoneArm Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Masking not possible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, controlled clinical trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor, MD, PhD

Study Record Dates

First Submitted

May 4, 2020

First Posted

May 13, 2020

Study Start

January 5, 2019

Primary Completion

December 1, 2022

Study Completion

January 1, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Not applicable: there is a commercial sponsor who provided the implants and the study data is available only by request.

Locations